Iron Oxide Nanoparticle Dynamic Contrast Enhancement Magnetic Resonance Imaging for Primary and Nodal Tumor in Locally Advanced Head and Neck Tumors: Data from a Terminated Phase 0 Feasibility Study Collection

This is the first and only extant matched ultra-small superparamagnetic iron oxides (USPIO)-enhanced magnetic resonance imaging (MRI) scans and clinical data of HNSCC patients where scans were acquired serially prior to radiotherapy (RT) course; as a part of a prospective Phase 0 study. This feasibility study led by Associate Professor Clifton D. Fuller, University of Texas MD Anderson Cancer Center (MDACC) represents a unique repository resource for scientists interested in molecular imaging of underlying tumor biology for other USPIO molecules, as well as those who may find capacity for additional development in HNSCC for USPIO for similar applications.